Alimera Sciences (ALIM) 8-K Alimera Sciences Announces the Appointment of Industry Veteran and Ophthalmology Business Executive John Snisarenko to its Board of Directors

Exhibit 10.62

Terms and Conditions of the Alimera Sciences, Inc.

2019 Non-Employee Director Compensation Program

Element	Description
Board Retainer	•$40,000 annual cash Board retainer
Chairman of the Board	•$45,000 annual cash retainer
Lead Independent Director	•$15,000 annual cash retainer
Committee Member (Non-Chair) Additional Annual Cash Retainer	•$10,000 for Audit Committee; •$7,000 for Compensation Committee; •$4,000 for Nominating & Governance Committee
Committee Chair Additional Annual Cash Retainer (includes amount for serving on Committee plus additional amount for serving as Chair)	•$20,000 for Audit Committee •$15,000 for Compensation Committee •$8,000 for Nominating & Governance Committee
Equity Compensation	•Annual grant for 50,000 stock options with a ten-year term and vest in equal monthly vesting installments over one year ØOption grants at the annual shareholder meeting (June), which is the beginning of the director “service year” ØNew directors are provided a pro-rata annual grant for service until the end of the current director “service year” ØDirectors to have three years to exercise vested options after leaving Board ØVesting accelerates in the event of a change in control of the Company or the director’s death or disability